Online Tool Enhances Decision-Making for Timing of Breast Reconstruction
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 -- An online decision aid is helpful for breast cancer patients deciding about immediate breast reconstruction (BR) after mastectomy, according to a study published in the October issue of Plastic and Reconstructive Surgery.
Jacqueline A. ter Stege, from the Netherlands Cancer Institute in Amsterdam, and colleagues evaluated the efficacy of an online decision aid in improving the decision-making process, decision quality, and health outcomes in 250 breast cancer patients considering immediate BR. Participants were allocated to the intervention (care as usual with access to an online decision aid) or the control group (care as usual with an information leaflet).
The researchers found that decisional conflict decreased over time in both groups, with no between-group differences. Participants in the intervention group felt better prepared for decision-making than controls. At three months after BR surgery, 87 percent of intervention participants were very satisfied with the information about BR compared with 73 percent of control participants. There were no significant between-group differences for any other outcome.
"The online format of the patient decision aid more easily allows for adaptions required by future developments in BR options and scientific evidence, and for the further tailoring of information to patients’ personal situation and information needs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-10 06:00
Read more
- Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
- Half of U.S. Teens Stare at Screens More Than 4 Hours Per Day
- Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades
- Healthy Eating Index 2015 Score Linked to Overactive Bladder
- AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
- Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions